Microaneurysm turnover at the macula predicts risk of development of clinically significant macular edema in persons with mild nonproliferative diabetic retinopathy.
Microaneurysm turnover at the macula predicts risk of development of clinically significant macular edema in persons with mild nonproliferative diabetic retinopathy.
Ribeiro, M.L., Nunes, S.G., Cunha-Vaz, J.
DIABETES CARE 2013, DOI:10.2337/DC121491
2013
Macular Thickness Measured by Stratus OCT in patients with Diabetes Type 2 and Mild Nonproliferative Retinopathy without Clinical evidence of Macular Edema.
Macular Thickness Measured by Stratus OCT in patients with Diabetes Type 2 and Mild Nonproliferative Retinopathy without Clinical evidence of Macular Edema.
Pires I.; Santos, A.; Nunes S.; Lobo C.
Ophthalmologica 2013; 229(4):181-186.
2013
Three Different Phenotypes of Mild Nonproliferative Diabetic Retinopathy with Different Risks for Development of Clinically Significant Macular Edema
Three Different Phenotypes of Mild Nonproliferative Diabetic Retinopathy with Different Risks for Development of Clinically Significant Macular Edema
Nunes S.; Ribeiro L.; Fonseca M.; Cunha-Vaz J.
DOI: 10.1167/iovs.13-11895
2013
Subclinical Macular Edema as a predictor of progression to Clinically Significant Macular Edema in Diabetes type 2
Subclinical Macular Edema as a predictor of progression to Clinically Significant Macular Edema in Diabetes type 2
Pires, I., Santos, A., Nunes, S., Lobo, C., Cunha-Vaz, J.
Ophthalmologica 230(4):201-6, 2013
2013
Choroidal thickness after treatment for myopic choroidal neovascularization
Choroidal thickness after treatment for myopic choroidal neovascularization
Farinha, C.L., Baltar, A.S., Nunes, S.G., Franqueira, N.F., Figueira, J.P., Pires, I.A., Cachulo, M.L., Silva, R.M.
Eur J Ophthalmol 2013 Jun 13:0; DOI: 10,5301/ejo.5000323
2013
Degree of Decrease in Central Retinal Thickness Predicts Visual Acuity Response to Intravitreal Ranibizumab in Diabetic Macular Edema
Degree of Decrease in Central Retinal Thickness Predicts Visual Acuity Response to Intravitreal Ranibizumab in Diabetic Macular Edema
Santos A.R., Gomes S.C., Figueira J., Nunes S., Lobo C.L., Cunha-Vaz J.G.
Ophthalmologica 2013; DOI: 10.1159/000355487
2013
Biomarkers of Diabetic Retinopathy
Biomarkers of Diabetic Retinopathy
Cunha-Vaz J, Ribeiro L, Nunes S, Lobo C.
Diabetes Manage 2014; 4(2), 181-192
2014
Degree of decrease in central retinal thickness predicts visual acuity response to intravitreal ranibizumab in diabetic macular edema.
Degree of decrease in central retinal thickness predicts visual acuity response to intravitreal ranibizumab in diabetic macular edema.
Santos AR; Gomes SC; Figueira J; Nunes S; Lobo CL; Cunha-Vaz JG
Ophthalmologica. 2014;231(1):16-22.
2014
Neurodegeneration in the diabetic Eye: new insights and terapeutic perspectives.
Neurodegeneration in the diabetic Eye: new insights and terapeutic perspectives.
Simó R; Hernández C; European Consortium for the Early Treatment of Diabetic Retinopathy (EUROCONDOR); Collaborators (17).
Trends Endocrinol Metab. 20104 Jan; 25(1):23-33. Epub 2013
2014
Drug-safety alerts issued by regulatory authorities: usefulness of meta-analysis in predicting earlier risks
Drug-safety alerts issued by regulatory authorities: usefulness of meta-analysis in predicting earlier risks
Carlos Alves, Francisco Batel Marques, Ana Filipa Macedo
European Journal of Clinical Pharmacology 2014. DOI:10.1007/s00228-014-1670-5
2014
